Clinical Trials Browser

Completed × Hormone Receptor Positive HER-2 Negative Breast Cancer × Clear all

NCT06705504 2024-11-26

A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib

Hormone Receptor Positive HER-2 Negative Breast Cancer

NCT02692755 2021-09-28

PALINA

Phase 2/3 Completed

35 enrolled 12 charts

Hormone Receptor Positive HER-2 Negative Breast Cancer